Randomised clinical trial investigating the effects of combined administration of octreotide and methylglucamine diatrizoate in the older persons with adhesive small bowel obstruction

Digestive and Liver Disease

Volumn 38, Issue 3, 2006, Pages 188-194

  Zhang, Y ^a   Gao, Y ^a   Ma, Q ^a   Dang, C ^a   Wei, W ^a   De Antoni, F ^c   Rocci, R ^b,c   Chen, W ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Methylglucamine diatrizoate; Octreotide; Small bowel obstruction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; CEFOTAXIME; COENZYME A; GLUCOSE; MEGLUMINE DIATRIZOATE; OCTREOTIDE; POTASSIUM CHLORIDE; PYRIDOXINE; VITAMIN K GROUP; CONTRAST MEDIUM; GASTROINTESTINAL AGENT;

ABDOMINAL DRAINAGE; ADHESION; AGED; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DRUG SAFETY; FEMALE; FLATULENCE; FOOD INTAKE; GANGRENE; GERIATRIC PATIENT; HOSPITAL READMISSION; HUMAN; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; PAIN ASSESSMENT; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE OBSTRUCTION; STATISTICAL SIGNIFICANCE; STRANGULATION; THERAPY EFFECT; DIGESTIVE TRACT INTUBATION; DRUG COMBINATION; INTESTINE OBSTRUCTION; PROSPECTIVE STUDY; SMALL INTESTINE;

ADHESIONS; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIATRIZOATE MEGLUMINE; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; INTUBATION, GASTROINTESTINAL; LENGTH OF STAY; MALE; OCTREOTIDE; PAIN MEASUREMENT; PATIENT READMISSION; PROSPECTIVE STUDIES;

EID: 33746091747     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.10.010     Document Type: Article

References (56)

1. Tanphiphat C., Chittmittrapap S., and Prasopsunti K. Adhesive small bowel obstruction. A review of 321 cases in a Thai hospital. Am J Surg 154 (1987) 238-247
2. Vantini I., Benini L., Bonfante F., Talamini G., Sembenini C., Chiarioni G., et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 36 (2004) 46-55
3. McEntee G., Pender D., Mulvin D., McCullough M., Naeeder S., Farah S., et al. Current spectrum of intestinal obstruction. Br J Surg 74 (1987) 976-980
4. Cooper J.M., and Thirlby R.C. Small bowel obstruction. Curr Treat Options Gastroenterol 5 (2002) 3-8
5. Zadeh B.J., Divis J.M., and Canizaro P.C. Small bowel obstruction in the older. Am Surg 8 (1985) 470-473
6. Choi H.K., Chu K.W., and Law W.L. Value of Gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective evaluation. World J Gastroenterol 11 (2005) 3742-3745
7. Williams S.B., Greenspon J., Young H.A., and Orkin B.A. Small bowel obstruction: conservative vs. surgical management. Dis Colon Rectum 48 (2005) 1140-1146
8. Fevang B.T., Jensen D., Svanes K., and Viste A. Early operation or conservative management of patients with small bowel obstruction. Eur J Surg 168 (2002) 475-481
9. Playforth R.H., Holloway J.B., and Griffen W.O. Mechanical small bowel obstruction: a plea for earlier operative therapy. Ann Surg 171 (1970) 783-788
10. Assalia A., Moshe S., Kopelman D., Hirshberg A., and Hashmonai M. Therapeutic effect of oral Gastrografin in adhesive, partial small bowel obstruction, a prospective randomised trial. Surgery 115 (1994) 433-437
11. Biondo S., Pares D., Mora L., Marti J., Kreisler E., and Jaurrieta E. Randomised clinical study of Gastrografin administration in patients with adhesive small bowel obstruction. Br J Surg 90 (2003) 542-546
12. Fevang B.T., Jensen D., Fevang J., Sondenaa K., Ovrebo K., Rokke O., et al. Upper gastrointestinal contrast study in the management of small bowel obstruction, a prospective randomised study. Eur J Surg 166 (2000) 39-43
13. Chen S.C., Chang K.J., and Lee P.H. Oral urographin in post-operative small bowel obstruction. World J Surg 23 (1999) 1051-1054
14. Chung C.C., Meng W.C.S., Yu S.C.H., Leung K.L., Lau W.Y., and Li A.K.C. A prospective study on the use of water-soluble contrast follow-through radiology in the management of small bowel obstruction. Aust N Z J Surg 66 (1996) 598-601
15. Onoue S., Katoh T., Shibata Y., Matsuo K., Suzuki M., and Chigira H. The value of contrast radiology for postoperative adhesive small bowel obstruction. Hepatogastroenterology 49 (2002) 1576-1578
16. Chen S.C., Lin F.Y., Lee P.H., Yu S.C., and Chang K.J. Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstruction. Br J Surg 85 (1998) 1692-1694
17. Choi H.K., Chu K.W., and Law W.L. Therapeutic value of Gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomised trial. Ann Surg 236 (2002) 1-6
18. Burge J., Abbas S.M., Roadley G., Donald J., Connolly A., Bissett I.P., and Hill A.G. Randomized controlled trial of Gastrografin in adhesive small bowel obstruction. ANZ J Surg 75 (2005) 672-674
19. Feigin E., Seror D., Szold A., Carmon M., Allweis T.M., Nissan A., et al. Water-soluble contrast material has no therapeutic effect on postoperative small bowel obstruction: results of a prospective, randomized clinical trial. Am J Surg 171 (1996) 227-229
20. Mercadante S. The role of octreotide in palliative care. J Pain Symptom Manage 9 (1994) 406-411
21. Mercadante S. Bowel obstruction in home care cancer patients. Support Care Cancer 3 (1995) 190-193
22. Khoo D., Hall E., Motson R., Riley J., Deman K., and Waxman J. Palliation of malignant intestinal obstruction using octreotide. Eur J Cancer 30 (1994) 28-30
23. Mercadante S., and Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Symptom Manage 7 (1992) 496-498
24. Mercadante S., Spoldi E., Caraceni A., Maddaloni S., and Simonetti M.T. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7 (1993) 295-299
25. Mangili G., Franchi M., Mariani A., Zanaboni F., Rabaiotti E., and Frigerio L. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol 61 (1996) 345-348
26. Brolin R.E. Partial small bowel obstruction. Surgery 95 (1984) 145-149
27. The CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
28. Tamburini M., Rosso S., and Gamba A. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Ann Oncol 3 (1992) 565-570
29. Lee J.F.Y., Meng W.C.S., Leung K.L., Yu S.C.H., Poon C.M., and Lau W.Y. Water soluble contrast follow-through in the management of adhesive small bowel obstruction: a prospective randomized trial. Ann Coll Surg HK 8 (2004) 120-126
30. Choi H.K., Chu K.W., and Law W.L. Can Gastrografin heal the obstructed bowel?. Gastroenterology 124 (2003) 852-854
31. Strodahl A., Laerum F., Gjolberg T., and Enge I. Water-soluble contrast media in radiography of small bowel obstruction. Acta Radiol 29 (1988) 53-56
32. Gelfand D.W. Complications of gastrointestinal radiologic procedure: Complications of routine fluoroscopic studies. Gastrointest Radiol 5 (1980) 239-315
33. Ott D.J., and Gelfand D.W. Gastrointestinal contrast agents: indications, uses and risks. J Am Med Assoc 249 (1983) 2380-2388
34. Trulzsch D.V., Penmetsa A., Karim A., and Evans D.A. Gastrografin-induced aspiration pneumonia: a lethal complication of computed tomography. South Med J 85 (1992) 1255-1256
35. Chrubasik J., Meynadier J., Blond S., Scherpereel P., Ackerman E., Weinstock M., et al. Somatostatin, a potent analgesic. Lancet 242 (1984) 1208-1209
36. Cascinu S., Del Ferro E., and Catalano G. A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. Br J Cancer 71 (1995) 97-101
37. Katai M., Sakurai A., Inaba H., Ikeo Y., Yamauchi K., and Hashizume K. Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor. Endocr J 52 (2005) 277-280
38. Penn R.D., Paice J.A., and Kroin J.S. Intrathecal octreotide for cancer pain. Lancet 335 (1990) 738
39. Befon S., Mystakidou K., Lyra M., Tubanakis N., and Vlahos L. Continuous subcutaneous octreotide in gastrointestinal cancer patients: pain control and B-endorphin levels. Anticancer Res 20 (2000) 4039-4046
40. Di Gregorio V.R., Ianniello G.P., and Rumero A. Octreotide for treatment of cancer pain. A pilot study. Eur J Cancer 27 Suppl. 2 (1991) s287
41. Tucci A., Carteni G., Biglietto M., Nicolella G.P., Riccardi F., and Pacilio G. A phase II study of octreotide in metastatic advanced prostatic cancer. Eur J Cancer 27 Suppl. 3 (1991) s88
42. Murase K., Nedeljkov V., and Randic M. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intracellular study. Brain Res 234 (1982) 170-176
43. Randic M., and Miletic V. Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli. Brain Res 152 (1978) 196-202
44. Ripamoni C., Panzeri C., and Groff L. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori 87 (2001) 1-9
45. Lamberts S.W.J., Der Lely A.J.V., Derlerder W.W., and Hotland L.J. Octreotide: drug therapy. In: Wood J.J.A. (Ed). The New England Journal of Medicine (1996), Medical Society, Massachusetts 246-253
46. Karalis K., Mastorakos G., Sano H., Wilder R.L., and Chrousos G.P. Somatostatin may participate in the antiinflammatory actions of glucocorticoids. Endocrinology 136 (1995) 4133-4138
47. Karalis K., Mastorakos G., Chrousos G.P., and Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest 93 (1994) 2000-2006
48. Liolios A., Oropello J.M., and Benjamin E. Gastrointestinal complications in the intensive care unit. Clin Chest Med 20 (1999) 329-345
49. Akyildiz M., Ersin S., Oymaci E., Dayangac M., Kapkac M., and Alkanat M. Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg 13 (2000) 169-173
50. Caty M.G., Guice K.S., and Oldjam K.T. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after ischemia-reperfusion injury. Ann Surg 212 (1990) 694-700
51. Koike K., Moore E.E., and Moore F.A. Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 22 (1994) 1438-1444
52. Aldemir M., Kokoglu O.F., Geyik M.F., and Buyukbyram H. Effects of octreotide acetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 198 (2002) 1-9
53. Mulvihill S., Pappas T.N., Passoro E., and Debas H.T. The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 100 (1986) 467-476
54. Cheadle W.G., Garr E.E., and Richardson J.D. The importance of early diagnosis of small bowel obstruction. Am Surg 54 (1988) 565-569
55. Akg N Y., Yilaz G., and Akbayin H. Causes and effective factors on mortality of intestinal obstruction in the south east Anatolia. Turk J Med Sci 32 (2002) 149-154
56. Beck D, Becker J, Fazio V, Wexner S. A symposium on prevention and treatment of adhesive small bowel obstruction. American Society of Colon and Rectal Surgeons; 1997.